A Cross-Sectional Study of the Microeconomic Impact of Cardiovascular Disease Hospitalization in Four Low- and Middle-Income Countries

Mark D. Huffman(Northwestern University), Krishna D. Rao(Public Health Foundation of India), Andrés Pichón-Rivière(Instituto de Efectividad Clínica y Sanitaria), Dong Zhao(Capital Medical University), S Harikrishnan(Sree Chitra Thirunal Institute for Medical Sciences and Technology), Kaushik Ramaiya(Muhimbili University of Health and Allied Sciences), Vamadevan S. Ajay(Centre for Chronic Disease Control), Shifalika Goenka(Center for Disease Dynamics, Economics and Policy), Juan Ignácio Calcagno(Instituto de Efectividad Clínica y Sanitaria), Joaquín Caporale(Instituto de Efectividad Clínica y Sanitaria), Shaoli Niu(PLA Navy General Hospital), Yan Li(Capital Medical University), Jing Liu(Capital Medical University), Kavumpurathu Raman Thankappan(Sree Chitra Thirunal Institute for Medical Sciences and Technology), Meena Daivadanam(Sree Chitra Thirunal Institute for Medical Sciences and Technology), Jan van Esch(Muhimbili University of Health and Allied Sciences), Adrianna Murphy(Harvard Global Health Institute), Andrew E. Moran(Columbia University Irving Medical Center), Thomas A. Gaziano(Brigham and Women's Hospital), Marc Suhrcke(University of East Anglia), K. Srinath Reddy(Center for Disease Dynamics, Economics and Policy), Stephen Leeder(The University of Sydney), Dorairaj Prabhakaran(Centre for Chronic Disease Control)
PLoS ONE
June 14, 2011
Cited by 264Open Access
Full Text

Abstract

OBJECTIVE: To estimate individual and household economic impact of cardiovascular disease (CVD) in selected low- and middle-income countries (LMIC). BACKGROUND: Empirical evidence on the microeconomic consequences of CVD in LMIC is scarce. METHODS AND FINDINGS: We surveyed 1,657 recently hospitalized CVD patients (66% male; mean age 55.8 years) from Argentina, China, India, and Tanzania to evaluate the microeconomic and functional/productivity impact of CVD hospitalization. Respondents were stratified into three income groups. Median out-of-pocket expenditures for CVD treatment over 15 month follow-up ranged from 354 international dollars (2007 INT$, Tanzania, low-income) to INT$2,917 (India, high-income). Catastrophic health spending (CHS) was present in >50% of respondents in China, India, and Tanzania. Distress financing (DF) and lost income were more common in low-income respondents. After adjustment, lack of health insurance was associated with CHS in Argentina (OR 4.73 [2.56, 8.76], India (OR 3.93 [2.23, 6.90], and Tanzania (OR 3.68 [1.86, 7.26] with a marginal association in China (OR 2.05 [0.82, 5.11]). These economic effects were accompanied by substantial decreases in individual functional health and productivity. CONCLUSIONS: Individuals in selected LMIC bear significant financial burdens following CVD hospitalization, yet with substantial variation across and within countries. Lack of insurance may drive much of the financial stress of CVD in LMIC patients and their families.


Related Papers

No related papers found

Powered by citation graph analysis